## CBOE: Cboe Global Markets, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.2% below STRENGTH zone (3.0-6.0%); PEG 2.09 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($242.75)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Discipline and Rules-Based Execution in CBOE Response**
- Source: Stock Traders Daily | 20260104T064800 | Neutral | Relevance: 100%
- This article provides a detailed AI-driven analysis for Cboe Global Markets Inc. (NASDAQ: CBOE), highlighting divergent sentiment across different time horizons. It outlines three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal analysis, support, and resistance levels for near-term, mid-term, and long-term outlooks.

**2. New York Stock Exchange owner ICE stock slips below $160 heading into key U.S. jobs week**
- Source: ts2.tech | 20260104T133508 | Somewhat-Bearish | Relevance: 63%
- Intercontinental Exchange (ICE), owner of the New York Stock Exchange, saw its stock decline by 1.2% to $159.99, starting 2026 on a softer note. The company's transaction revenue is tied to trading volumes, and investors are now focused on upcoming U.S. jobs data to gauge its potential impact on interest-rate expectations and market activity. ICE's fourth-quarter 2025 earnings call on February 5th will be a key event for investors.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $240 | $221 | +9% |
| 2025-12-12 | Barclays | $302 | $273 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Underweight |
| 2025-12-12 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (+0.0%)
- Blackrock Inc.: 9.0% (-2.7%)
- Alliancebernstein L.: 6.1% (-31.2%)
- State Street Corpora: 4.5% (+2.1%)
- FMR, LLC: 4.3% (+62.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.09 elevated, pricing in significant growth expectations. Forward P/E 23.1x stretched relative to 5% growth. Quality metrics strong (ROE 22%, margin 21%). Analyst sentiment positive (2 raises, avg +10%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.4B |
| Beta | 0.36 |
| 52W Range | $187.30 - $262.98 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.09 |
| Forward P/E | 23.1 |
| Current P/E | 24.3 |
| YoY Growth | 5.2% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 0.9% to -0.2% (-1.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.2pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.06x) but short-term weakness (below SMA20). RSI neutral at 49. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.23% (CS: 36) | Neutral |
| RSI_14 | 49.4 | Neutral |
| MACD Histogram | -0.24 | Bearish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 1.000x | Below |
| vs SMA200 | 1.064x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $251.83
- **Stop Loss:** $242.75 (3.6% risk)
- **Target:** $260.91 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 151
- **Position Value:** $38,026.33
- **Portfolio %:** 38.03%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-06 (Est: $2.73)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.53 | $2.67 | +5.6% |
| 2025Q2 | $2.44 | $2.46 | +0.6% |
| 2025Q1 | $2.36 | $2.50 | +5.8% |
| 2024Q4 | $2.12 | $2.10 | -0.9% |

---
*RULE-based L3 | 2026-01-07 09:35 | MRS_10*